Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen for Persistent Post-concussive Symptoms
NCT05173818Phase 2Completed
- Sponsor
- Essentia Health
- Start
- Jun 2022
- Primary completion
- Aug 2025
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hyperbaric oxygen therapy in Post-concussion syndrome (PCS) (2 arms), sponsored by Essentia Health. Primary endpoint: Repeatable Battery for the Assessment of Neuropsychological Status at 12 months. Started Jun 2022; status: completed.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
Post-concussion syndrome (PCS)
Beyond the preview
Go deeper on NCT05173818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05173818.